首页> 外文期刊>The European Journal of Neuroscience >The antidepressant fluoxetine but not citalopram suppresses synapse formation and synaptic transmission between Lymnaea neurons by perturbing presynaptic and postsynaptic machinery.
【24h】

The antidepressant fluoxetine but not citalopram suppresses synapse formation and synaptic transmission between Lymnaea neurons by perturbing presynaptic and postsynaptic machinery.

机译:抗抑郁药氟西汀但不抑制西酞普兰通过扰动突触前和突触后机制来抑制突触神经元之间的突触形成和突触传递。

获取原文
获取原文并翻译 | 示例
       

摘要

Depression is a debilitating mental disorder, and selective serotonin reuptake inhibitors (SSRIs) constitute the first-line antidepressant treatment choice for the clinical management of this illness; however, the mechanisms underlying their therapeutic actions and side effects remain poorly understood. Here, we compared the effects of two SSRIs, fluoxetine and citalopram, on synaptic connectivity and the efficacy of cholinergic synaptic transmission between identified presynaptic and postsynaptic neurons from the mollusc Lymnaea. The in vitro paired cells were exposed to clinically relevant concentrations of the two SSRIs under chronic and acute experimental conditions, and the incidence of synapse formation and the efficacy of synaptic transmission were tested electrophysiologically and with fluorescent Ca(2+) imaging. We demonstrate that chronic exposure to fluoxetine, but not to citalopram, inhibits synapse formation and reduces synaptic strength, and that these effects are reversible following prolonged drug washout. At the structural level, we demonstrate that fluoxetine, but not citalopram, prevents the expression and localization of the presynaptic protein synaptophysin. Acute exposure to fluoxetine substantially reduced synaptic transmission and synaptic plasticity (post-tetanic potentiation) in established synapses, whereas citalopram reduced synaptic transmission, but not short-term synaptic plasticity. We further demonstrate that fluoxetine, but not citalopram, directly inhibits voltage-gated Ca(2+) currents in the presynaptic neuron, as well as postsynaptic responsiveness to exogenously applied neurotransmitter. This study provides the first direct evidence that fluoxetine and citalopram exert characteristic, non-specific side effects that are unrelated to their function as SSRIs, and that fluoxetine is more detrimental to synaptic physiology and structure than citalopram.
机译:抑郁症是一种使人衰弱的精神疾病,选择性5-羟色胺再摄取抑制剂(SSRI)构成该疾病临床治疗的一线抗抑郁治疗选择。然而,对其治疗作用和副作用的潜在机制仍知之甚少。在这里,我们比较了两个SSRIs(氟西汀和西酞普兰)对突触连接性和从软体动物Lymnaea突触前和突触后神经元之间胆碱能突触传递的功效的影响。在慢性和急性实验条件下,将体外配对细胞暴露于临床相关浓度的两种SSRIs,并通过电生理学和荧光Ca(2+)成像测试突触形成的发生率和突触传递的功效。我们证明长期暴露于氟西汀而不是西酞普兰会抑制突触形成并降低突触强度,并且长时间的药物冲洗后这些作用是可逆的。在结构水平上,我们证明氟西汀而不是西酞普兰阻止突触前蛋白突触素的表达和定位。急性暴露于氟西汀可显着降低已建立突触的突触传递和突触可塑性(强直后增强),而西酞普兰可降低突触传递,但不能降低短期突触可塑性。我们进一步证明氟西汀,但不是西酞普兰,直接抑制电压门控的Ca(2+)电流在突触前神经元,以及对外源应用神经递质的突触后反应。这项研究提供了第一个直接证据,氟西汀和西酞普兰具有与SSRI的功能无关的特征性,非特异性副作用,并且氟西汀比西酞普兰对突触生理和结构的危害更大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号